NCT02538172View on ClinicalTrials.gov

Cell-mediated Immunity for Prevention of CMV Disease

NACompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2021

Conditions
Cytomegalovirus Infections
Interventions
OTHER

T-Track® CMV assay

Trial Locations (5)

1205

Hopitaux Universitaires de Genève, Geneva

3010

Universitätsspital Bern, Bern

4051

Universität Basel, Basel

8091

UniversitätsSpital Zürich, Zurich

9007

Kantonsspital St.Gallen, Sankt Gallen

All Listed Sponsors
lead

University of Lausanne Hospitals

OTHER

NCT02538172 - Cell-mediated Immunity for Prevention of CMV Disease | Biotech Hunter | Biotech Hunter